Lyme disease is surging across southeastern Ontario as black-legged ticks invade backyards, trails, and parks, driving a sharp rise in infections that health officials can no longer ignore.
Caused by the bacteria Borrelia burgdorferi, Lyme disease often strikes with deceptive early symptoms or no symptoms at all. This includes fatigue, fever, and the telltale bullseye rash, which sometimes doesn’t come until weeks or months later.
Lyme is a stealthy, corkscrew-shaped spiral bacterium that drills deep into tissues, joints, and the nervous system, making it incredibly difficult to detect and hard to eradicate.
Missed early treatment can lead to chronic, debilitating pain, inflammation, and long-term illness. This can be amplified by a lack of initial symptoms or pesky co-infections, including Babesia, Bartonella, Anaplasma, and Ehrlichia.
Due to a high variability of symptoms, there aren’t necessarily textbook presentations, which can complicate diagnoses and treatment leading to more severe or atypical manifestations.
In the United States, they’re confronting this epidemic head-on.
HHS Secretary Kennedy announced concrete action to tackle Lyme, including a major multi-million-dollar tick control pilot, up to $2.5 million in Lyme innovation challenges, improved diagnostics, and a goal to reduce cases by 25% by 2035 relative to 2022 levels.